{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:21:58Z","timestamp":1787430118994,"version":"build-2736575974"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1053\/j.ajkd.2015.09.013","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T19:58:46Z","timestamp":1445716726000},"page":"318-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Pathogenesis of Hepatorenal Syndrome: Implications for Therapy"],"prefix":"10.1053","volume":"67","author":[{"given":"Fran\u00e7ois","family":"Durand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Graupera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra K.","family":"Nadim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.ajkd.2015.09.013_bib1","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib3","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib4","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1053\/j.ajkd.2015.09.013_bib5","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib6","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib9","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/MCG.0b013e31822e8e12","article-title":"Acute Kidney Injury Network criteria as a predictor of hospital mortality in cirrhotic patients with ascites","volume":"46","author":"de Carvalho","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of\u00a0impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"issue":"4","key":"10.1053\/j.ajkd.2015.09.013_bib12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: pathogenesis and clinical relevance","volume":"11","author":"Wiese","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","article-title":"Left ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction","volume":"58","author":"Nazar","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1007295","article-title":"Hepatorenal disorders: role of the renin-angiotensin-aldosterone system","volume":"14","author":"Bernardi","year":"1994","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0168-8278(98)80022-6","article-title":"The sympathetic nervous system in liver disease","volume":"29","author":"Henriksen","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.1976.65","article-title":"Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis","volume":"9","author":"Schroeder","year":"1976","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2362.1981.tb01844.x","article-title":"Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites","volume":"11","author":"Arroyo","year":"1981","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.510290203","article-title":"Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis","volume":"29","author":"Schneider","year":"1999","journal-title":"Hepatology"},{"issue":"12","key":"10.1053\/j.ajkd.2015.09.013_bib24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/gut.28.12.1637","article-title":"Hepatic intestinal uptake and release of catecholamines in alcoholic cirrhosis. Evidence of enhanced hepatic intestinal sympathetic nervous activity","volume":"28","author":"Henriksen","year":"1987","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2362.1991.tb01816.x","article-title":"Plasma noradrenaline in cirrhosis: a study of kinetics and temporal relationship to ascites formation","volume":"21","author":"Macgilchrist","year":"1991","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"10.1053\/j.ajkd.2015.09.013_bib26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/gut.25.10.1034","article-title":"Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis","volume":"25","author":"Henriksen","year":"1984","journal-title":"Gut"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-116-6-446","article-title":"Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis","volume":"116","author":"Esler","year":"1992","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(91)90222-7","article-title":"Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites","volume":"100","author":"Claria","year":"1991","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1053\/j.ajkd.2015.09.013_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ki.2010.4","article-title":"Afferent mechanisms of sodium retention in cirrhosis and hepatorenal syndrome","volume":"77","author":"Oliver","year":"2010","journal-title":"Kidney Int"},{"issue":"25","key":"10.1053\/j.ajkd.2015.09.013_bib30","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJM199212173272502","article-title":"Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome","volume":"327","author":"Moore","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.21940","article-title":"Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome","volume":"47","author":"Wong","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/hep.1840160126","article-title":"Plasma levels of brain natriuretic peptide in patients with cirrhosis","volume":"16","author":"La Villa","year":"1992","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/hep.1840080333","article-title":"Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction","volume":"8","author":"Gines","year":"1988","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2015.04.004","article-title":"Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: a case-control study","volume":"63","author":"Elia","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodriguez","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib39","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib40","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1053\/j.ajkd.2015.09.013_bib41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2009.04.017","article-title":"The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome","volume":"51","author":"Cazzaniga","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib43","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2011.12.030","article-title":"C-Reactive protein predicts short-term mortality in patients with cirrhosis","volume":"56","author":"Cervoni","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension - the undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib45","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/liv.12559","article-title":"Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure","volume":"35","author":"Mehta","year":"2015","journal-title":"Liver Int"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib48","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","article-title":"Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival","volume":"59","author":"Oettl","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib49","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and\u00a0ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/jhep.2003.50304","article-title":"Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis","volume":"38","author":"De las Heras","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib53","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib55","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2011.11.023","article-title":"Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study","volume":"56","author":"Pereira","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1053\/j.ajkd.2015.09.013_bib56","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival","volume":"59","author":"Barreto","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib57","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","article-title":"Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure","volume":"46","author":"Thabut","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib58","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib59","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MEG.0b013e3283435d76","article-title":"Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo","volume":"23","author":"Tyagi","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib60","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","article-title":"Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis","volume":"138","author":"Lebrec","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1053\/j.ajkd.2015.09.013_bib61","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2015.09.013_bib62","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2014.05.014","article-title":"Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial","volume":"61","author":"Park","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib63","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib64","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib65","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.ajkd.2015.09.013_bib67","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"9","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1053\/j.ajkd.2015.09.013_bib68","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib69","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib71","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","article-title":"Terlipressin for hepatorenal syndrome: a meta-analysis of randomized trials","volume":"32","author":"Fabrizi","year":"2009","journal-title":"Int J Artif Organs"},{"issue":"4, pt 1","key":"10.1053\/j.ajkd.2015.09.013_bib73","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib74","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1053\/j.ajkd.2015.09.013_bib76","doi-asserted-by":"crossref","first-page":"e107466","DOI":"10.1371\/journal.pone.0107466","article-title":"Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nassar Junior","year":"2014","journal-title":"PloS One"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib77","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib78","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"issue":"7","key":"10.1053\/j.ajkd.2015.09.013_bib79","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome","volume":"43","author":"Skagen","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib80","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib82","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib83","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib84","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0016-5085(00)70033-3","article-title":"MARS: a new treatment for hepatorenal failure. Molecular adsorbent and recirculating system","volume":"119","author":"Kapoor","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib85","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.500060326","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib86","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/jhep.2002.0350492","article-title":"Treatment of hepatorenal syndrome: lessons from the MARS trial","volume":"35","author":"Mullen","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2015.09.013_bib87","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib88","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepato-renal syndrome post liver transplantation","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib89","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1053\/j.ajkd.2015.09.013_bib90","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1","volume":"17","author":"Boyer","year":"2011","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1053\/j.ajkd.2015.09.013_bib91","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","article-title":"Simultaneous liver-kidney transplantation: evaluation to decision making","volume":"7","author":"Davis","year":"2007","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2015.09.013_bib92","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2015.09.013_bib93","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2015.09.013_bib94","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00134-010-1887-4","article-title":"Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury","volume":"36","author":"Martensson","year":"2010","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib95","doi-asserted-by":"crossref","first-page":"e0128145","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PloS One"},{"issue":"11","key":"10.1053\/j.ajkd.2015.09.013_bib96","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib97","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"issue":"9","key":"10.1053\/j.ajkd.2015.09.013_bib98","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1053\/j.ajkd.2015.09.013_bib99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhep.2014.02.023","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections","volume":"61","author":"Barreto","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.09.013_bib100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1053\/j.ajkd.2015.09.013_bib101","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-148-11-200806030-00003","article-title":"Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury","volume":"148","author":"Nickolas","year":"2008","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2015.09.013_bib102","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00134-009-1711-1","article-title":"Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population","volume":"36","author":"Cruz","year":"2010","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1053\/j.ajkd.2015.09.013_bib103","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1111\/j.1600-6143.2012.04182.x","article-title":"Outcomes and native renal recovery following simultaneous liver-kidney transplantation","volume":"12","author":"Levitsky","year":"2012","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2015.09.013_bib104","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/hep.27346","article-title":"Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation","volume":"60","author":"Levitsky","year":"2014","journal-title":"Hepatology"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615012238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615012238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:47:19Z","timestamp":1759459639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638615012238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0272638615012238"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.09.013","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of Hepatorenal Syndrome: Implications for Therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}